CARCINOMA, PANCREATIC DUCTAL
Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear
Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human test of Pfizer's new cancer pill targets tough tumors
Disease control OngoingThis is an early safety study for a new oral medicine, PF-07985045, designed for people with advanced solid tumors that have a specific KRAS gene mutation. The study will test the medicine by itself and combined with other cancer treatments to find a safe dose and see how the bod…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients test new pfizer cancer drug in early safety trial
Disease control OngoingThis is an early-stage study to test the safety and initial effects of a new drug called PF-08046037. It is being tested alone and in combination with another immunotherapy drug (sasanlimab) in people with advanced or spreading cancers, including lung, head and neck, skin, and pa…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC